Isabel Marzo

Full Professor

Universidad de Zaragoza

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Isabel Marzo is a Full Professor at the University of Zaragoza in Spain. Her research focuses on the interplay of targeted therapies in hematological malignancies, particularly in Multiple Myeloma and B-CLL. Recent publications highlight her work on innovative treatment combinations and the molecular mechanisms underlying cancer cell death. She is dedicated to advancing therapeutic strategies through the study of tumor interactions and immune response.

Articles (13)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

martin villalba

CNRS Délégation Languedoc-Roussillon

FRANCE

View details

M. Concepción Gimeno

SPAIN

View details

Alberto Anel

Professor

Universidad de Zaragoza

SPAIN

View details

Miguel Monge

University of La Rioja

SPAIN

View details

Joaquín Marco-Brualla

Assistant Professor

Universidad CEU San Pablo

SPAIN

View details

José M. López-de-Luzuriaga

Universidad Internacional de La Rioja

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Isabel Marzo

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL

Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat

Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak

Silver‐Based Terpyridine Complexes as Antitumor Agents

Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients

Conjugation of the 9-kDa Isoform of Granulysin with Liposomes Potentiates Its Cytotoxicity

Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma

Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis

Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5‐f]‐1,10‐phenanthroline core

Synthesis of New Thiourea-Metal Complexes with Promising Anticancer Properties

Dual Emissive Ir(III) Complexes for Photodynamic Therapy and Bioimaging

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Collaborators (6)

martin villalba

M. Concepción Gimeno

Alberto Anel

Miguel Monge

Joaquín Marco-Brualla

José M. López-de-Luzuriaga

Make your next move.